Status:
UNKNOWN
BIOPSY SCANNER LLTECH© Technology for Diagnosis of Breast Cancer
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Breast cancer is a frequent pathology and the speed of initial diagnosis makes it possible to improve the course of care and to reduce the anxiety of the patients. For a complete assessment, several b...
Detailed Description
In France, 59,000 new cases of breast cancer are diagnosed per year, but with systematic screening, more than 400,000 women will be biopsied each year. Less than 50% of women in France respond to orga...
Eligibility Criteria
Inclusion
- Patients over 18 years old requiring a breast biopsy for an birads 4 or 5 nodular radiological lesion or lymph node for a lymph node judged to be radiologically suspect (cortex thickened by more than 3 mm)
Exclusion
- Patients under 18
Key Trial Info
Start Date :
April 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2021
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT04292821
Start Date
April 28 2020
End Date
September 15 2021
Last Update
May 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital de la Pitié Salpêtrière
Paris, France, 75013